tailieunhanh - A novel treatment strategy for lapatinib resistance in a subset of HER2-amplified gastric cancer

Gastric cancer (GC) is one of the leading causes of cancer-related deaths worldwide. Human epidermal growth factor receptor 2 (HER2) amplification occurs in approximately 13–23% of all GC cases and patients with HER2 overexpression exhibit a poor prognosis. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN